Status:
COMPLETED
Progesterone for Postpartum Cocaine Relapse
Lead Sponsor:
Yale University
Collaborating Sponsors:
National Institute on Drug Abuse (NIDA)
Conditions:
Cocaine Abuse
Cocaine Dependence
Eligibility:
FEMALE
18-50 years
Phase:
NA
Brief Summary
The investigators propose a placebo-controlled, randomized clinical trial that would enroll 50 postpartum women with a history of cocaine abuse or dependence to assess whether progesterone (100mgs twi...
Detailed Description
Specific Aim 1: To evaluate whether postpartum women with a history of cocaine abuse or dependence use less cocaine if they are randomized to progesterone than placebo. Hypothesis 1: Compared to wome...
Eligibility Criteria
Inclusion
- Gravidas (women who delivered a baby in the past 12 weeks) who are 18 or older are eligible to participate.
- Women must meet diagnostic criteria for abuse or dependence of cocaine in the six-months prior to conception or during pregnancy.
- Women who abuse other illicit substances or alcohol would also be eligible as long as cocaine was their primary drug of abuse. If women are also opiate dependent, they must be undergoing treatment with methadone or buprenorphine. While we propose to target cocaine we will also monitor the ability of women with polysubstance use to maintain abstinence from substances other than cocaine.
Exclusion
- Women will be ineligible for the trial if they:
- have a history of major medical illnesses including liver diseases, suspected or known malignancy, thrombophlebitis, deep vein thrombosis, pulmonary embolus, clotting or bleeding disorders, heart disease, diabetes, history of stroke or other medical conditions that the physician investigator deems as contraindicated for participation in the study;
- have a known allergy to progesterone or peanuts (vehicle for micronized progesterone);
- speak a language other than English;
- are planning on moving out of the area in the first six months after delivery;
- are unable to understand the study or are unable to provide informed consent;
- are currently undergoing treatment with another pharmacological agent for substance abuse treatment (with the exception of methadone or buprenorphine as above);
- have pending incarceration;
- are currently incarcerated;
- are using another progestin;
- are unwilling to accept randomization;
- are unwilling to use a barrier method of birth control for the duration of the study to ensure that they will not become pregnant.
Key Trial Info
Start Date :
February 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2013
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT01249274
Start Date
February 1 2011
End Date
July 1 2013
Last Update
March 28 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Yale School of Medicine
New Haven, Connecticut, United States, 06510